Centene (CNC) Stock Still Looks Cheap As Its 100% Run Continues

Centene has almost doubled over the past year, and with the stock around US$74 the real question for you now is whether that move is supported by the health insurer's earnings power. After a strong run driven by improving margins and cost cuts, the valuation debate has shifted firmly onto what the current profit profile can justify.

• The share price has gained 99.9% over the past year, which puts real pressure on today’s earnings to warrant that kind of re-rating.
• Recent margin improvements in Medicare and Marketplace plans, together with debt reduction and automation efforts, can influence how durable Centene's future earnings and cash generation look.
• Your read on Centene is one view; the desks covering it have another. See what analysts think Centene's shares could be worth.

The stock's next move may depend on whether Centene's current earnings are strong enough to support the valuation implied by the recent share price performance.

If you are weighing whether Centene's 99.9% 1 year gain is fully justified by its earnings, a focused stock screen built around similar valuation questions can be a useful second reference point through 42 high quality undervalued stocks.

Does Centene Look Undervalued on Earnings?

The P/E ratio suits Centene because earnings are a key focus for investors after the recent margin work and cost cuts. At a current P/E of 25.2x, the stock trades slightly below the wider Healthcare industry average of 25.8x and also below peers on roughly 28.8x. For a business tied so closely to government programs, that kind of gap can matter because even modest shifts in expectations around profitability or contract risk can affect what investors are willing to pay.

Because a tailored fair P/E for Centene screens higher than where the shares trade now, the multiple suggests the stock is undervalued on this earnings lens. The raised 2026 earnings guidance after a solid Q3 means the market already has some of that improvement in view, yet the P/E still trails both peers and that modelled fair level. For anyone tracking Centene after its sharp price move, this leaves the share price looking more like it is lagging the current earnings profile than racing ahead of it. Explore the numbers behind Centene's P/E valuation.

The Centene Narrative: What Would Justify Today's Price?

Narratives for Centene pick up where the P/E debate leaves off and explain which paths for growth, margins and earnings would need to occur for the current valuation to look stretched or conservative. Instead of stopping at a single ratio or model output, they unpack the future that number relies on so you can track how Centene's actual progress compares with those underlying assumptions on Simply Wall St's Community page.

Community views on Centene split between one group that sees more upside in the current setup and another that treats the stock as roughly fairly valued.

Bull case: 13% undervalued

"The Marketplace book is evolving toward a higher acuity Silver membership mix with sizeable risk adjustment receivables, which opens the door for Centene to treat this segment as a capital light fee platform..."

Discover why this Narrative puts Centene at 13% undervalued.

Bear case: roughly fairly valued

"Medicaid margin recovery is currently progressing more slowly than some investors expected, and with full year 2026 Medicaid membership now expected to decline 8% to 9% from year end 2025 due to tighter eligibility and OB3 related actions..."

Explore why this Narrative puts Centene at roughly fairly valued.

Centene's price is visible, but the story behind future expectations is still offstage

Valuation only tells you what the market is willing to pay for Centene today, while the projected profit path a few years out offers a separate reference point that investors track closely. Explore where analysts expect Centene to be in a few years.

Have feedback on this article? Concerned about the content? Get in touch with us directly. Alternatively, email editorial-team@simplywallst.com